CN114668817A - Pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart - Google Patents

Pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart Download PDF

Info

Publication number
CN114668817A
CN114668817A CN202210191082.7A CN202210191082A CN114668817A CN 114668817 A CN114668817 A CN 114668817A CN 202210191082 A CN202210191082 A CN 202210191082A CN 114668817 A CN114668817 A CN 114668817A
Authority
CN
China
Prior art keywords
parts
root
heart
radix
pharmaceutical formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210191082.7A
Other languages
Chinese (zh)
Inventor
王永春
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202210191082.7A priority Critical patent/CN114668817A/en
Publication of CN114668817A publication Critical patent/CN114668817A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/14Cupressaceae (Cypress family), e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/346Platycodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704Polygonum, e.g. knotweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/84Valerianaceae (Valerian family), e.g. valerian
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965Asparagus, e.g. garden asparagus or asparagus fern
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968Ophiopogon (Lilyturf)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969Polygonatum (Solomon's seal)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart, which comprises ginseng, astragalus root, ophiopogon root, asparagus root, dried orange peel, platycodon root, sealwort, notoginseng, nardostachys root, bupleurum root, prepared rehmannia root, tuber fleeceflower stem, licorice root and the like, and the pharmaceutical formulation has the effects of clearing and activating the channels and collaterals, promoting blood circulation to remove blood stasis, tonifying qi and nourishing yin, and stopping palpitation and recovering pulse and the like, can tonify qi and blood, improve microcirculation, enhance myocardial contractility and the like, and can effectively treat symptoms such as palpitation, shortness of breath, hypodynamia, dizziness, palpitation, chest distress, chest pain and the like caused by blood stasis of heart vessels, not only can be suitable for treating arrhythmia including ventricular premature beat and atrial premature beat, but also can be used for quickly recovering after heart operation (such as cardiac stent operation and the like), and has obvious curative effect.

Description

Pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart
Technical Field
The invention relates to the technical field of medicines, in particular to a medicine formula for treating arrhythmia and postoperative recovery of heart.
Background
Arrhythmia is a common cardiovascular disease in clinic, and is divided into fast arrhythmia and slow arrhythmia, including atrial fibrillation, atrial flutter, atrial tachycardia, ventricular fibrillation, atrial premature beat, ventricular premature beat, sinus bradycardia, conduction block, sick sinus syndrome, etc. In traditional Chinese medicine, arrhythmia is classified into the categories of palpitation and severe palpitation.
At present, western medicine has no special-effect medicine with lasting curative effect on arrhythmia, mainly treats pacemaker implantation, radiofrequency ablation, arrhythmia control medicine and the like, but still some patients have palpitation symptoms and various arrhythmia after treatment, and have large toxic and side effects.
Disclosure of Invention
Therefore, based on the above background, the present invention provides a pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart, so as to effectively treat arrhythmia, including atrial premature beat, ventricular premature beat, etc.
The technical scheme provided by the invention is as follows:
a pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart comprises Ginseng radix, radix astragali, radix Ophiopogonis, radix asparagi, pericarpium Citri Tangerinae, radix Platycodi, rhizoma Polygonati, Notoginseng radix, rhizoma et radix Valerianae, bupleuri radix, radix rehmanniae Preparata, caulis Polygoni Multiflori, radix Angelicae sinensis, Os Draconis, Concha Ostreae, ramulus Uncariae cum uncis, semen Ziziphi Spinosae, Poria, lalang grass rhizome, semen Platycladi, cortex moutan, radix Paeoniae alba, and Glycyrrhrizae radix.
Preferably, the weight ratio of the raw materials is as follows:
5-10 parts of ginseng, 10-30 parts of astragalus membranaceus, 6-12 parts of radix ophiopogonis, 6-12 parts of radix asparagi, 20-30 parts of pericarpium citri reticulatae, 3-9 parts of platycodon grandiflorum, 10-15 parts of rhizoma polygonati, 3-9 parts of pseudo-ginseng, 3-6 parts of nardostachyos root and rhizome, 5-10 parts of radix bupleuri, 15-30 parts of prepared rehmannia root, 10-20 parts of tuber fleeceflower stem, 5-10 parts of angelica sinensis, 15-30 parts of dragon bone, 15-30 parts of oyster, 10-30 parts of uncaria, 10-20 parts of spina date seed, 10-15 parts of poria with hostwood, 10-30 parts of lalang grass rhizome, 10-20 parts of platycladi seed, 9-10 parts of cortex moutan, 5-12 parts of radix paeoniae alba and 3-9 parts of liquorice.
The pseudo-ginseng in the formula of the invention has the functions of removing blood stasis, stopping bleeding, reducing swelling and relieving pain; radix astragali has effects of invigorating qi, consolidating superficial resistance, promoting urination, expelling pus, healing sore, and promoting granulation; ophiopogon root has the effects of nourishing yin, moistening lung, clearing away heart-fire, relieving restlessness, reinforcing stomach and promoting fluid production; the dried orange peel can regulate qi, invigorate spleen, eliminate dampness and reduce phlegm; the platycodon grandiflorum has the effects of dispersing lung qi, relieving sore throat, eliminating phlegm and expelling pus; rhizoma Polygonati has effects of invigorating spleen, replenishing qi, nourishing yin and moistening lung; notoginseng dispels blood stasis to stop bleeding, detumescence and relieve pain; rhizoma Nardostachyos regulates qi to alleviate pain, and relieves stagnation and invigorates spleen; bupleurum root, radix bupleuri harmonizes exterior and interior, soothes liver and raises yang; the prepared rehmannia root has the effects of nourishing yin and blood, and replenishing essence and marrow; caulis Polygoni Multiflori is effective in nourishing heart, tranquilizing mind, dredging collaterals, and dispelling pathogenic wind; the liquorice tonifies spleen and qi, clears heat and toxic materials, eliminates phlegm and stops coughing, relieves spasm and pain, and harmonizes the medicines; angelica sinensis has the effects of enriching blood, promoting blood circulation, regulating menstruation and relieving pain; fossil fragments are sedated, sweat and essence are astringed, tissue regeneration is promoted and sores are healed; concha Ostreae has effects of tranquilizing mind, suppressing yang hyperactivity, nourishing yin, softening and resolving hard mass; ramulus Uncariae cum uncis has effects of clearing heat, calming liver, calming endogenous wind and arresting convulsion; the spina date seed has the effects of tonifying liver, calming heart, arresting sweating and promoting the production of body fluid; poria with hostwood tranquilizes; the cogongrass rhizome is used for cooling blood and stopping bleeding, clearing heat and promoting urination; semen Platycladi has effects of nourishing heart, tranquilizing mind, arresting sweating, and moistening intestine; cortex moutan has effects of clearing heat and cooling blood, and promoting blood circulation for removing blood stasis; the white peony root has the effects of calming the liver, relieving pain, nourishing blood, regulating menstruation, astringing yin and suppressing sweating; the traditional Chinese medicine composition has the effects of clearing and activating the channels and collaterals, promoting blood circulation to remove blood stasis, tonifying qi and yin, stopping palpitation and recovering pulse, calming the nerves and calming the heart and the like, can tonify qi and blood, improve microcirculation, enhance myocardial contractility and the like, can effectively treat symptoms such as palpitation, shortness of breath and hypodynamia, dizziness and palpitation, chest distress and chest pain and the like caused by heart blood stasis, is suitable for treating arrhythmia including ventricular premature beat and atrial premature beat, can also be used for quickly recovering after cardiac operation (such as cardiac stent operation and the like), and has obvious curative effect.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are some embodiments of the present invention, but not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1: a pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart comprises 5-10 parts of ginseng, 10-30 parts of astragalus membranaceus, 6-12 parts of radix ophiopogonis, 6-12 parts of radix asparagi, 20-30 parts of pericarpium citri reticulatae, 3-9 parts of platycodon grandiflorum, 10-15 parts of rhizoma polygonati, 3-9 parts of pseudo-ginseng, 3-6 parts of nardostachyos root and rhizome, 5-10 parts of radix bupleuri, 15-30 parts of prepared rehmannia root, 10-20 parts of tuber fleeceflower stem, 3-9 parts of liquorice, 5-10 parts of angelica sinensis, 15-30 parts of dragon bone, 15-30 parts of oyster, 10-30 parts of uncaria, 10-20 parts of spina date seed, 10-15 parts of poria with hostwood, 10-30 parts of lalang grass rhizome, 10-20 parts of platycladi seed, 9-10 parts of cortex moutan and 5-12 parts of radix paeoniae alba.
In specific implementation, the traditional Chinese medicine composition is prepared into an oral preparation which is prepared from a pure traditional Chinese medicine formula, is sweet and slightly bitter in taste, is 200ml in 1 bag, and is taken 1 time each time in the morning and evening each day.
Example 2: clinical cases
Case 1, Zhangzhi, 38 years old, first diagnosis 5 months and 3 days in 2003. Palpitations for three more months.
Initial diagnosis: the patient feels that the heartbeat is accelerated, sometimes, the arrhythmia and the premature beat are displayed by recently checking the dynamic electrocardiogram, and part of the arrhythmia and the premature beat are in a bigeminal rhythm and a trigeminy rhythm. The symptoms are as follows: palpitations, paroxysmal and intermittent, feeling of fullness in the stomach and chest, no desire to eat, insomnia, little tongue coating and intermittent pulse.
Dialectical analysis: qi and yin deficiency, phlegm-fire disturbing the interior.
Therapeutic method: tonify qi, nourish yin, clear heat, resolve phlegm, induce tranquilization.
The medicine is decocted with water for taking, and one dose is taken in one day, and ten doses are taken in total. The patient has a retest in 6 months in 2003, the palpitation is obviously improved, the sleep is improved, no obvious discomfort exists, the arrhythmia is fully cured, no recurrence exists until now after follow-up for years, and the body is healthy.
Case 2: li Shi, female, 57 years old, first diagnosis 4/7/2010. Palpitation, shortness of breath, physical weakness, shortness of breath, asthma, and poor breathing.
Initial diagnosis: the patient has a history of hypertension, palpitation and short breath, repeated attack, bedridden and shortbreath after walking. A recent 24-hour electrocardiogram was performed: arrhythmia is manifested as premature beat, occasionally forming an acute atrial tachycardia. Displaying the heart color ultrasound: EF: 64%, and hypovolemic left ventricular function. The symptoms are as follows: palpitation, shortness of breath, lassitude, chest oppression, aggravation after exercise, heavy sensation in the head, no desire to eat, poor sleep quality, frequent urination, pale and dark tongue with white coating, and intermittent pulse. The patient is diagnosed with emotional stress and anxiety.
Dialectical analysis: heart-qi and yin deficiency, phlegm-stasis.
Therapeutic method: supplementing qi and nourishing yin, stimulating appetite and reducing phlegm, and promoting blood circulation by removing blood stasis.
The medicine is decocted with water for taking, and one dose is taken in one day, and ten doses are taken in total. And (4) twice diagnosis in 16 days: the symptoms of chest distress and short breath of the patients are improved without obvious uncomfortable feeling, and the patients need to take the traditional Chinese medicine continuously. The tongue coating is pale and dark, the pulse is intermittent, and ten doses are administered later.
Three diagnoses in 4 months and 26 days: the patients still feel palpitation, the attack frequency is reduced before, the tongue coating is pale and dark, and the pulse is long.
Four diagnoses in 5 months and 6 days: the symptoms of the patient disappear, and the patient does not relapse.
The invention is applied to the treatment of arrhythmia patients for years, and the total effective rate of the comprehensive curative effect reaches 98.3 percent, and the curative effect is obvious.
The present invention and the embodiments thereof have been described above, but the description is not limited thereto, and the embodiments shown in the examples are only one of the embodiments of the present invention, and the actual structure is not limited thereto. In summary, those skilled in the art should appreciate that they can readily use the disclosed conception and specific embodiments as a basis for designing or modifying other structures for carrying out the same purposes of the present invention without departing from the spirit and scope of the invention as defined by the appended claims.

Claims (2)

1. A pharmaceutical formulation for treating arrhythmia and heart postoperative recovery is characterized by comprising ginseng, astragalus mongholicus, radix ophiopogonis, radix asparagi, pericarpium citri reticulatae, platycodon grandiflorum, rhizoma polygonati, pseudo-ginseng, rhizoma nardostachyos, radix bupleuri, prepared rehmannia root, tuber fleeceflower stem, angelica sinensis, dragon bone, oyster, uncaria, spina date seed, poria with hostwood, lalang grass rhizome, platycladi seed, cortex moutan, radix paeoniae alba and liquorice.
2. The pharmaceutical formulation for the treatment of arrhythmia and post-operative recovery of the heart according to claim 1, wherein the raw materials used in the following weight ratios are:
5-10 parts of ginseng, 10-30 parts of astragalus membranaceus, 6-12 parts of radix ophiopogonis, 6-12 parts of radix asparagi, 20-30 parts of pericarpium citri reticulatae, 3-9 parts of platycodon grandiflorum, 10-15 parts of rhizoma polygonati, 3-9 parts of pseudo-ginseng, 3-6 parts of nardostachyos root and rhizome, 5-10 parts of radix bupleuri, 15-30 parts of prepared rehmannia root, 10-20 parts of tuber fleeceflower stem, 5-10 parts of angelica sinensis, 15-30 parts of dragon bone, 15-30 parts of oyster, 10-30 parts of uncaria, 10-20 parts of spina date seed, 10-15 parts of poria with hostwood, 10-30 parts of lalang grass rhizome, 10-20 parts of platycladi seed, 9-10 parts of cortex moutan, 5-12 parts of radix paeoniae alba and 3-9 parts of liquorice.
CN202210191082.7A 2022-02-25 2022-02-25 Pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart Pending CN114668817A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210191082.7A CN114668817A (en) 2022-02-25 2022-02-25 Pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210191082.7A CN114668817A (en) 2022-02-25 2022-02-25 Pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart

Publications (1)

Publication Number Publication Date
CN114668817A true CN114668817A (en) 2022-06-28

Family

ID=82071701

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210191082.7A Pending CN114668817A (en) 2022-02-25 2022-02-25 Pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart

Country Status (1)

Country Link
CN (1) CN114668817A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105770399A (en) * 2016-04-23 2016-07-20 包晓娜 Traditional Chinese medicine composition for treating arrhythmia

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105770399A (en) * 2016-04-23 2016-07-20 包晓娜 Traditional Chinese medicine composition for treating arrhythmia

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘峰等: "中医药治疗缓慢性心律失常进展", 《甘肃中医》 *
张国斌: "归脾丸合逍遥散加减治疗顽固性早搏42例", 《吉林中医药》 *

Similar Documents

Publication Publication Date Title
CN102755593A (en) Traditional Chinese medicine composition for treating qi goiter and preparation method thereof
CN111298019B (en) Traditional Chinese medicine for treating tachyarrhythmia
CN102114231B (en) Medicine for treating arrhythmia
CN100512852C (en) Composite Chinese medicine took orally for treating coronary heart disease
CN103479969B (en) A kind of medicine for the treatment of manic-depressive psychosis and preparation method thereof
CN102908391B (en) Chinese medicinal composition for treating dermatosis and preparation method and application thereof
CN104491166A (en) Traditional Chinese medicine composition with auxiliary anesthetic effect
CN102430085B (en) Chinese medicine for treating coronary heart disease
CN104606561A (en) Traditional Chinese medicinal composition for treating spontaneous perspiration
CN101284093B (en) Chinese herb medicine for treating coronary heart disease
CN1966050A (en) Medicament for treating heart disease and preparation process thereof
CN103860773A (en) Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof
CN114668817A (en) Pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart
CN101757465B (en) Traditional Chinese medicine capsule for treating cervical spondylosis, lumbar disc herniation, cervicodynia and lumbodynia
CN110882347A (en) A Chinese medicinal composition for treating cardiovascular diseases
CN104873911A (en) Traditional Chinese medicine for oral administration for adjunctively treating sepsis
CN111388564B (en) Traditional Chinese medicine for treating bradyarrhythmia
CN104367984A (en) Traditional Chinese medicine formula for treating aged coronary heart disease
CN114504635B (en) Chinese patent medicine for treating apoplexy sequela
CN102755625A (en) Traditional Chinese medicine combination for treating myocardial blood deficiency syndrome and preparation method
CN101983712A (en) Novel medicament for treating coronary heart disease
CN101569708B (en) Medicament for treating ischemic heart disease and preparation method thereof
CN101607007B (en) Traditional Chinese medicine preparation for treating cerebral circulation insufficiency
CN106692821A (en) Traditional Chinese medicine preparation for treating neurosurgical postoperative headache
CN106511698A (en) Traditional Chinese medicine for treating hypertension

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination